Germany
Review Article
The Metabolic Syndrome and Cardiovascular Diseases: An Update of Medical Treatment
Author(s): Markolf Hanefeld, Frank Pistrosch, Jan Schulze and Ulrike RotheMarkolf Hanefeld, Frank Pistrosch, Jan Schulze and Ulrike Rothe
The metabolic syndrome represents a cluster of closely connected premorbid risk factors or diseases with visceral obesity, prediabetes or type 2 diabetes, hypertension and low dyslipidemia as established traits affecting about 20 % of adults in developed countries. This syndrome develops on a common soil with overnutrition, low physical activity and psychosocial stress as major components. Common comorbidities are fatty liver, sleep apnoe and gout with cardiovascular complications, nephropathy and type 2 diabetes as ‘endstage’ diseases. The term metabolic vascular syndrome was proposed to signal premorbid cardiovascular state and increased cardiovascular morbidity. Thus, a rational diagnostic is needed to elucidate the complex cluster of diseases as basis for an integrated therapy. There is a clear priority for life style intervention however most diseases of the metabolic.. Read More»
DOI:
10.4172/2167-0943.1000160
Journal of Metabolic Syndrome received 48 citations as per Google Scholar report